Dual roles of vascular-derived reactive oxygen species-With a special reference to hydrogen peroxide and cyclophilin A-

Journal of Molecular and Cellular Cardiology

Volumn 73, Issue , 2014, Pages 50-56

  Satoh, Kimio ^a   Godo, Shigeo ^a   Saito, Hiroki ^a   Enkhjargal, Budbazar ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Reactive oxygen species; Vascular diseases; Vascular homeostasis

Indexed keywords

ANTIOXIDANT; CYCLOPHILIN A; HYDROGEN PEROXIDE; NITRIC OXIDE; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE;

ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; DISEASE ASSOCIATION; HOMEOSTASIS; HUMAN; HYPERPOLARIZATION; MEMBRANE TRANSPORT; MOLECULARLY TARGETED THERAPY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASODILATATION; ANIMAL; CARDIOVASCULAR DISEASE; METABOLISM;

ANIMALS; CARDIOVASCULAR DISEASES; CYCLOPHILIN A; HUMANS; HYDROGEN PEROXIDE; MUSCLE, SMOOTH, VASCULAR; REACTIVE OXYGEN SPECIES;

EID: 84901857447     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.12.022     Document Type: Review

References (74)

1. Shimokawa H., Tomoike H., Nabeyama S., Yamamoto H., Araki H., Nakamura M., et al. Coronary artery spasm induced in atherosclerotic miniature swine. Science 1983, 221:560-562.
2. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 1999, 31:23-37.
3. Berk B.C. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 2001, 81:999-1030.
4. Taniyama Y., Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003, 42:1075-1081.
5. Burgoyne J.R., Oka S., Ale-Agha N., Eaton P. Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system. Antioxid Redox Signal 2013, 18:1042-1052.
6. Griendling K.K., Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J Lab Clin Med 1998, 132:9-15.
7. Alexander R.W. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995, 25:155-161.
8. Omar H.A., Cherry P.D., Mortelliti M.P., Burke-Wolin T., Wolin M.S. Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relaxation. Circ Res 1991, 69:601-608.
9. - in vascular smooth muscle cells. Circ Res 1995, 77:29-36.
10. Vanhoutte P.M. Endothelium-derived free radicals: for worse and for better. J Clin Invest 2001, 107:23-25.
11. Matoba T., Shimokawa H., Nakashima M., Hirakawa Y., Mukai Y., Hirano K., et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 2000, 106:1521-1530.
12. Morikawa K., Shimokawa H., Matoba T., Kubota H., Akaike T., Talukder M.A., et al. Pivotal role of Cu, Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J Clin Invest 2003, 112:1871-1879.
13. Takaki A., Morikawa K., Tsutsui M., Murayama Y., Tekes E., Yamagishi H., et al. Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. J Exp Med 2008, 205:2053-2063.
14. Zhang D.X., Borbouse L., Gebremedhin D., Mendoza S.A., Zinkevich N.S., Li R., et al. H2O2-induced dilation in human coronary arterioles: role of protein kinase G dimerization and large-conductance Ca2+-activated K+ channel activation. Circ Res 2012, 110:471-480.
15. Katusic Z.S., Schugel J., Cosentino F., Vanhoutte P.M. Endothelium-dependent contractions to oxygen-derived free radicals in the canine basilar artery. Am J Physiol 1993, 264:H859-H864.
16. Iida Y., Katusic Z.S. Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke 2000, 31:2224-2230.
17. Sandow S.L. Factors, fiction and endothelium-derived hyperpolarizing factor. Clin Exp Pharmacol Physiol 2004, 31:563-570.
18. Shao D., Oka S., Brady C.D., Haendeler J., Eaton P., Sadoshima J. Redox modification of cell signaling in the cardiovascular system. J Mol Cell Cardiol 2012, 52:550-558.
19. Takaki A., Morikawa K., Murayama Y., Yamagishi H., Hosoya M., Ohashi J., et al. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice. J Cardiovasc Pharmacol 2008, 52:510-517.
20. Cohen R.A., Adachi T. Nitric-oxide-induced vasodilatation: regulation by physiologic s-glutathiolation and pathologic oxidation of the sarcoplasmic endoplasmic reticulum calcium ATPase. Trends Cardiovasc Med 2006, 16:109-114.
21. Sumimoto H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J 2008, 275:3249-3277.
22. Wu C., Parrott A.M., Fu C., Liu T., Marino S.M., Gladyshev V.N., et al. Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies. Antioxid Redox Signal 2011, 15:2565-2604.
23. Lassegue B., San M.A., Griendling K. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 2012, 110:1364-1390.
24. Vanhoutte P.M., Shimokawa H., Tang E.H., Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol 2009, 196:193-222.
25. Shimokawa H. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pflugers Arch 2010, 459:915-922.
26. Feletou M., Vanhoutte P.M. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988, 93:515-524.
27. Chen G., Suzuki H., Weston A.H. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol 1988, 95:1165-1174.
28. Feletou M., Vanhoutte P.M. Endothelium-dependent hyperpolarizations: past beliefs and present facts. Ann Med 2007, 39:495-516.
29. Prysyazhna O., Rudyk O., Eaton P. Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension. Nat Med 2012, 18:286-290.
30. Burgoyne J.R., Madhani M., Cuello F., Charles R.L., Brennan J.P., Schroder E., et al. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007, 317:1393-1397.
31. Burgoyne J.R., Prysyazhna O., Rudyk O., Eaton P. cGMP-dependent activation of protein kinase G precludes disulfide activation: implications for blood pressure control. Hypertension 2012, 60:1301-1308.
32. Ohashi J., Sawada A., Nakajima S., Noda K., Takaki A., Shimokawa H. Mechanisms for enhanced endothelium-derived hyperpolarizing factor-mediated responses in microvessels in mice. Circ J 2012, 76:1768-1779.
33. Nakajima S., Ohashi J., Sawada A., Noda K., Fukumoto Y., Shimokawa H. Essential role of bone marrow for microvascular endothelial and metabolic functions in mice. Circ Res 2012, 111:87-96.
34. Lu T., He T., Katusic Z.S., Lee H.C. Molecular mechanisms mediating inhibition of human large conductance Ca2+-activated K+ channels by high glucose. Circ Res 2006, 99:607-616.
35. Fleming I., Michaelis U.R., Bredenkotter D., Fisslthaler B., Dehghani F., Brandes R.P., et al. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 2001, 88:44-51.
36. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994, 74:1141-1148.
37. Vanhoutte P.M. Say NO, to ET. J Auton Nerv Syst 2000, 81:271-277.
38. Yang D., Feletou M., Boulanger C.M., Wu H.F., Levens N., Zhang J.N., et al. Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol 2002, 136:104-110.
39. Auch-Schwelk W., Katusic Z.S., Vanhoutte P.M. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 1989, 13:859-864.
40. Rao G.N., Berk B.C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992, 70:593-599.
41. Liao D.F., Jin Z.G., Baas A.S., Daum G., Gygi S.P., Aebersold R., et al. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem 2000, 275:189-196.
42. Jin Z.G., Melaragno M.G., Liao D.F., Yan C., Haendeler J., Suh Y.A., et al. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 2000, 87:789-796.
43. Shimokawa H. Reactive oxygen species promote vascular smooth muscle cell proliferation. Circ Res 2013, 113:1040-1042.
44. Schroder E., Eaton P. Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations. Curr Opin Pharmacol 2008, 8:153-159.
45. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984, 226:544-547.
46. Marks A.R. Cellular functions of immunophilins. Physiol Rev 1996, 76:631-649.
47. Galat A., Metcalfe S.M. Peptidylproline cis/trans isomerases. Prog Biophys Mol Biol 1995, 63:67-118.
48. Theuerkorn M., Fischer G., Schiene-Fischer C. Prolyl cis/trans isomerase signalling pathways in cancer. Curr Opin Pharmacol 2011, 11:281-287.
49. Zhu C., Wang X., Deinum J., Huang Z., Gao J., Modjtahedi N., et al. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med 2007, 204:1741-1748.
50. Krummrei U., Bang R., Schmidtchen R., Brune K., Bang H. Cyclophilin-A is a zinc-dependent DNA binding protein in macrophages. FEBS Lett 1995, 371:47-51.
51. Soe N., Sowden M., Baskaran P., Smolock E., Kim Y., Nigro P., et al. Cyclophilin A is required for angiotensin II-induced p47phox translocation to caveolae in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2013, 33:2147-2153.
52. Suzuki J., Jin Z.G., Meoli D.F., Matoba T., Berk B.C. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res 2006, 98:811-817.
53. Satoh K., Nigro P., Matoba T., O'Dell M.R., Cui Z., Shi X., et al. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med 2009, 15:649-656.
54. Satoh K., Fukumoto Y., Shimokawa H. Rho-kinase: important new therapeutic target in cardiovascular diseases. Am J Physiol Heart Circ Physiol 2011, 301:H287-H296.
55. Satoh K., Nigro P., Berk B.C. Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A. Antioxid Redox Signal 2010, 12:675-682.
56. Satoh K., Shimokawa H., Berk B.C. Cyclophilin A: promising new target in cardiovascular therapy. Circ J 2010, 74:2249-2256.
57. Jin Z.G., Lungu A.O., Xie L., Wang M., Wong C., Berk B.C. Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Arterioscler Thromb Vasc Biol 2004, 24:1186-1191.
58. Nigro P., Satoh K., O'Dell M.R., Soe N.N., Cui Z., Mohan A., et al. Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 2011, 208:53-66.
59. Pushkarsky T., Zybarth G., Dubrovsky L., Yurchenko V., Tang H., Guo H., et al. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc Natl Acad Sci U S A 2001, 98:6360-6365.
60. Satoh K., Matoba T., Suzuki J., O'Dell M.R., Nigro P., Cui Z., et al. Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation 2008, 117:3088-3098.
61. Satoh K., Nigro P., Zeidan A., Soe N.N., Jaffre F., Oikawa M., et al. Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2011, 31:1116-1123.
62. Bell R.D., Winkler E.A., Singh I., Sagare A.P., Deane R., Wu Z., et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012, 485:512-516.
63. Montezano A.C., Touyz R.M. Molecular mechanisms of hypertension-reactive oxygen species and antioxidants: a basic science update for the clinician. Can J Cardiol 2012, 28:288-295.
64. Satoh K., Fukumoto Y., Nakano M., Sugimura K., Nawata J., Demachi J., et al. Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1. Cardiovasc Res 2009, 81:226-234.
65. Satoh K., Fukumoto Y., Sugimura K., Miura Y., Aoki T., Nochioka K., et al. Plasma Cyclophilin A is a novel biomarker for coronary artery disease. Circ J 2013, 77:447-455.
66. Kesarwani P., Murali A.K., Al-Khami A.A., Mehrotra S. Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal 2013, 18:1497-1534.
67. Shimokawa H., Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005, 25:1767-1775.
68. Wang Y.X., Martin-McNulty B., da Cunha V., Vincelette J., Lu X., Feng Q., et al. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation 2005, 111:2219-2226.
69. Shimizu T., Fukumoto Y., Tanaka S.I., Satoh K., Ikeda S., Shimokawa H. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice. Arterioscler Thromb Vasc Biol 2013, 33:2780-2791.
70. Higashi M., Shimokawa H., Hattori T., Hiroki J., Mukai Y., Morikawa K., et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 2003, 93:767-775.
71. Ejiri J., Inoue N., Tsukube T., Munezane T., Hino Y., Kobayashi S., et al. Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker. Cardiovasc Res 2003, 59:988-996.
72. Habashi J.P., Judge D.P., Holm T.M., Cohn R.D., Loeys B.L., Cooper T.K., et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006, 312:117-121.
73. Cassis L.A., Rateri D.L., Lu H., Daugherty A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 2007, 27:380-386.
74. Weintraub N.L. Understanding abdominal aortic aneurysm. N Engl J Med 2009, 361:1114-1116.